The complete 685-kilobase DNA sequence of the human β T cell receptor locus

Science

Volumn 272, Issue 5269, 1996, Pages 1755-1762

  Rowen, Lee ^a   Koop, Ben F ^b   Hood, Leroy ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF VICTORIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ARTICLE; DNA SEQUENCE; GENE EXPRESSION; GENE LOCUS; GENOME; HUMAN; HUMAN CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0030017526     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.272.5269.1755     Document Type: Article

References (65)

1. L. Hood, J. Campbell, S. Elgin, Annu. Rev Genet. 9, 305 (1975).
2. For example, see R. Wilson et al., Nature 368, 32 (1994), R. D. Fleischmann et al., Science 269, 496 (1995).
3. For example, see R. Wilson et al., Nature 368, 32 (1994), R. D. Fleischmann et al., Science 269, 496 (1995).
4. M. D. Adams, C. Fields, J Venter, Eds., Automated DNA Sequencing and Analysis (Academic Press, London, 1994).
5. P. Green, personal communication.
6. M. M. Davis and P. J. Bjorkman, Nature 334, 395 (1988); J. L. Jorgensen, P. A. Reay, E. W. Enrich, M. M. Davis, Annu. Rev. Immunol. 10, 835 (1992).
7. M. M. Davis and P. J. Bjorkman, Nature 334, 395 (1988); J. L. Jorgensen, P. A. Reay, E. W. Enrich, M. M. Davis, Annu. Rev. Immunol. 10, 835 (1992).
8. M. R. Ueber, FASEB J. 5, 2934 (1991).
9. For example, see P. Concannon, A A. Pickering, P. Kung, L. Hood, Proc. Natl. Acad. Sci. U.S.A. 83, 6598 (1986); N. Kimura, B Toyonaga, Y. Yoshikai, R.-P. Du, T. W. Mak, Eur. J. Immunol. 17, 375 (1987); J. P. Tillinghast, M. A. Behlke, D. Y. Loh, Science 233, 879 (1986).
10. For example, see P. Concannon, A A. Pickering, P. Kung, L. Hood, Proc. Natl. Acad. Sci. U.S.A. 83, 6598 (1986); N. Kimura, B Toyonaga, Y. Yoshikai, R.-P. Du, T. W. Mak, Eur. J. Immunol. 17, 375 (1987); J. P. Tillinghast, M. A. Behlke, D. Y. Loh, Science 233, 879 (1986).
11. For example, see P. Concannon, A A. Pickering, P. Kung, L. Hood, Proc. Natl. Acad. Sci. U.S.A. 83, 6598 (1986); N. Kimura, B Toyonaga, Y. Yoshikai, R.-P. Du, T. W. Mak, Eur. J. Immunol. 17, 375 (1987); J. P. Tillinghast, M. A. Behlke, D. Y. Loh, Science 233, 879 (1986).
12. J. L. Slightom, D R. Siemieniak, L. C. Sieu, B. F. Koop, L Hood, Genomics 20, 149 (1994).
13. G. Siu, E. C. Strauss, E. Lai, L. E. Hood, J Exp Med. 164, 1600 (1986); B. Toyonaga, Y. Yoshikai, V. Vadasz, B. Chin, T. W. Mak, Proc. Natl. Acad. Sci U.S.A. 82, 8624 (1985); R. K. Wilson et al., Immunol. Rev. 101, 149 (1988); S. Wei, P. Charmley, M A. Robinson, P. Concannon, Immunogenetics 40, 27 (1994); T. M. Zhao, S. E. Whitaker, M. A. Robinson, J. Exp. Med. 180, 1405 (1994).
14. G. Siu, E. C. Strauss, E. Lai, L. E. Hood, J Exp Med. 164, 1600 (1986); B. Toyonaga, Y. Yoshikai, V. Vadasz, B. Chin, T. W. Mak, Proc. Natl. Acad. Sci U.S.A. 82, 8624 (1985); R. K. Wilson et al., Immunol. Rev. 101, 149 (1988); S. Wei, P. Charmley, M A. Robinson, P. Concannon, Immunogenetics 40, 27 (1994); T. M. Zhao, S. E. Whitaker, M. A. Robinson, J. Exp. Med. 180, 1405 (1994).
15. G. Siu, E. C. Strauss, E. Lai, L. E. Hood, J Exp Med. 164, 1600 (1986); B. Toyonaga, Y. Yoshikai, V. Vadasz, B. Chin, T. W. Mak, Proc. Natl. Acad. Sci U.S.A. 82, 8624 (1985); R. K. Wilson et al., Immunol. Rev. 101, 149 (1988); S. Wei, P. Charmley, M A. Robinson, P. Concannon, Immunogenetics 40, 27 (1994); T. M. Zhao, S. E. Whitaker, M. A. Robinson, J. Exp. Med. 180, 1405 (1994).
16. G. Siu, E. C. Strauss, E. Lai, L. E. Hood, J Exp Med. 164, 1600 (1986); B. Toyonaga, Y. Yoshikai, V. Vadasz, B. Chin, T. W. Mak, Proc. Natl. Acad. Sci U.S.A. 82, 8624 (1985); R. K. Wilson et al., Immunol. Rev. 101, 149 (1988); S. Wei, P. Charmley, M A. Robinson, P. Concannon, Immunogenetics 40, 27 (1994); T. M. Zhao, S. E. Whitaker, M. A. Robinson, J. Exp. Med. 180, 1405 (1994).
17. G. Siu, E. C. Strauss, E. Lai, L. E. Hood, J Exp Med. 164, 1600 (1986); B. Toyonaga, Y. Yoshikai, V. Vadasz, B. Chin, T. W. Mak, Proc. Natl. Acad. Sci U.S.A. 82, 8624 (1985); R. K. Wilson et al., Immunol. Rev. 101, 149 (1988); S. Wei, P. Charmley, M A. Robinson, P. Concannon, Immunogenetics 40, 27 (1994); T. M. Zhao, S. E. Whitaker, M. A. Robinson, J. Exp. Med. 180, 1405 (1994).
18. Y. Li, P. Szabo, D. N. Posnett, J Exp. Med. 174, 1537 (1991).
19. Candidate cosmids encompassing the β TCR locus were identified by screening libraries constructed from yeast artificial chromosome (YAC) DNA or total genomic DNA with probes prepared from V gene segments, β locus-specific sequence-tagged sites, or human repetitive DNA (for cosmids derived from YACs). These cosmids were derived from the DNA of six different individuals (libranes), representing 12 possible distinct haplotypes. A physical map of 139 cosmid clones was constructed by a combination of Southern (DNA) blot hybridization, restriction digest analysis, and alignment of DNA sequence from the ends of cosmid inserts with completed sequence contigs (33). This cosmid array represents a sevenfold average coverage of the locus. The complete DNA sequence of the locus was obtained by applying a high-redundancy (eightfold coverage) shotgun method to 23 cosmids (47) and a primer-walking directed method to three cosmids (8). The sequence and its annotation are deposited in the Genome Sequence Data Base (accession numbers L36092, L36190, and U03115). On the basis of resequencing >60 kb of DNA, we estimate that the sequence contains, on average, one error per 5 kb. For specific details of the sequencing strategy (including chemistry, assembly of repeats, and precision estimates), see (47).
20. Non-TCR genes were identified by Xgrail (version 1.2) and BlastX. Similarity analyses were performed with the Smith-Waterman comparison algorithm on a Masspar Supercomputer (MpSRCH; Intelligenetics), with the Inherit analysis program (Applied Biosystems), or with cross_match (4).
21. B. Arden, S. P Clark, D. Kabelitz, T. W. Mak, Immunogenetics 42, 455 (1995).
22. β 4S1 (29-1).
23. T W. Mak and Y. Yanagi, Immunol. Rev. 81, 221 (1984).
24. H. D. Royer and E. L. Reinherz, Proc. Natl. Acad. Sci. U S.A. 84, 232 (1987); S J Anderson, S. Miyake, D. Y. Loh, Mol. Cell. Biol 9, 4835 (1989).
25. H. D. Royer and E. L. Reinherz, Proc. Natl. Acad. Sci. U S.A. 84, 232 (1987); S J Anderson, S. Miyake, D. Y. Loh, Mol. Cell. Biol 9, 4835 (1989).
26. B. F. Koop et al., Genomics 19, 478 (1994); J. E. Hesse, M R. Lieber, K. Mizuuchi. M. Gellert, Genes Dev. 3, 1053 (1989)
27. B. F. Koop et al., Genomics 19, 478 (1994); J. E. Hesse, M R. Lieber, K. Mizuuchi. M. Gellert, Genes Dev. 3, 1053 (1989)
28. D. N Posnett et al., J. Exp. Med 179, 1707 (1994).
29. β genes holds true for the quantitative or statistical representation studies that have been performed. For additional expression data, see P. J. Doherty et al., Mol. Immunol. 28, 607 (1991): W. M. C Rosenberg, P A. H Moss, J. I. Bell, Eur. J. Immunol. 22, 541 (1992); M. A. Hall and J. S. Lanchbury, Hum. Immunol. 43, 207 (1995).
30. β genes holds true for the quantitative or statistical representation studies that have been performed. For additional expression data, see P. J. Doherty et al., Mol. Immunol. 28, 607 (1991): W. M. C Rosenberg, P A. H Moss, J. I. Bell, Eur. J. Immunol. 22, 541 (1992); M. A. Hall and J. S. Lanchbury, Hum. Immunol. 43, 207 (1995).
31. β genes holds true for the quantitative or statistical representation studies that have been performed. For additional expression data, see P. J. Doherty et al., Mol. Immunol. 28, 607 (1991): W. M. C Rosenberg, P A. H Moss, J. I. Bell, Eur. J. Immunol. 22, 541 (1992); M. A. Hall and J. S. Lanchbury, Hum. Immunol. 43, 207 (1995).
32. U Malhotra, R. Spielman, P. Concannon, J. Immunol. 149, 1802 (1992).
33. R. Jores and T Meo, ibid. 151, 6110 (1993).
34. F. J. Bollum and L M. S. Chang, Adv. Cancer Res 47, 37 (1986).
35. M. Levitt, personal communication.
36. M. D. Adams et al., Nature 377 (suppl.), 3 (1995).
37. M. Emi et al., Gene 41, 305 (1986).
38. T Tani, I. Kawashima, K. Mita, Y. Takiguchi, Nucleic Acids Res. 18, 1631 (1990)
39. U. Wiegand, S. Corbach, A Minn, J. Kang, B. Muller-Hill, Gene 136, 167 (1993).
40. C. L. M. J. Verlinde and W. G. J Hol, personal communication.
41. J. Roach, personal communication.
42. L. Rowen, unpublished data
43. K. Wang, personal communication.
44. T. Hunkapiller and L. Hood, Adv. Immunol. 44, 1 (1989).
45. For details of the construction of the map for the β TCR locus (for which fluorescence in srtu hybridization was performed by H. Massa and B. Trask), see L. Rowen et al., in preparation.
46. Six of the translocated V genes have been identified by M. A. Robinson et al., Proc. Natl. Acad. Sci. U.S.A. 90, 2433 (1993).
47. For review of coding region polymorphisms, see (13). For examples of restriction fragment length polymorphisms, see M. A. Robinson and T. J. Kindt, Hum Immunol. 14, 195 (1985); P. Concannon et at., Cold Spring Harbor Symp. Quant. Biol. 51, 785 (1986); P. Charmley, P. Concannon, R. A. Gatti, Tissue Antigens 35, 157 (1990); P Charmley, K. Wang, L. Hood, D. Nickerson. J. Exp. Med 177, 135 (1993); S W. Funkhouser, P. Concannon, P. Charmley, D. L. Vredevoe, L. Hood, Arthritis Hheum. 35, 466 (1992). the number of sequence variations obtained from our analysis of overlapping cosmids is too small to draw generalizations about the frequency of coding versus noncoding polymorphisms in the germline sequence.
48. For review of coding region polymorphisms, see (13). For examples of restriction fragment length polymorphisms, see M. A. Robinson and T. J. Kindt, Hum Immunol. 14, 195 (1985); P. Concannon et at., Cold Spring Harbor Symp. Quant. Biol. 51, 785 (1986); P. Charmley, P. Concannon, R. A. Gatti, Tissue Antigens 35, 157 (1990); P Charmley, K. Wang, L. Hood, D. Nickerson. J. Exp. Med 177, 135 (1993); S W. Funkhouser, P. Concannon, P. Charmley, D. L. Vredevoe, L. Hood, Arthritis Hheum. 35, 466 (1992). the number of sequence variations obtained from our analysis of overlapping cosmids is too small to draw generalizations about the frequency of coding versus noncoding polymorphisms in the germline sequence.
49. For review of coding region polymorphisms, see (13). For examples of restriction fragment length polymorphisms, see M. A. Robinson and T. J. Kindt, Hum Immunol. 14, 195 (1985); P. Concannon et at., Cold Spring Harbor Symp. Quant. Biol. 51, 785 (1986); P. Charmley, P. Concannon, R. A. Gatti, Tissue Antigens 35, 157 (1990); P Charmley, K. Wang, L. Hood, D. Nickerson. J. Exp. Med 177, 135 (1993); S W. Funkhouser, P. Concannon, P. Charmley, D. L. Vredevoe, L. Hood, Arthritis Hheum. 35, 466 (1992). the number of sequence variations obtained from our analysis of overlapping cosmids is too small to draw generalizations about the frequency of coding versus noncoding polymorphisms in the germline sequence.
50. For review of coding region polymorphisms, see (13). For examples of restriction fragment length polymorphisms, see M. A. Robinson and T. J. Kindt, Hum Immunol. 14, 195 (1985); P. Concannon et at., Cold Spring Harbor Symp. Quant. Biol. 51, 785 (1986); P. Charmley, P. Concannon, R. A. Gatti, Tissue Antigens 35, 157 (1990); P Charmley, K. Wang, L. Hood, D. Nickerson. J. Exp. Med 177, 135 (1993); S W. Funkhouser, P. Concannon, P. Charmley, D. L. Vredevoe, L. Hood, Arthritis Hheum. 35, 466 (1992). the number of sequence variations obtained from our analysis of overlapping cosmids is too small to draw generalizations about the frequency of coding versus noncoding polymorphisms in the germline sequence.
51. For review of coding region polymorphisms, see (13). For examples of restriction fragment length polymorphisms, see M. A. Robinson and T. J. Kindt, Hum Immunol. 14, 195 (1985); P. Concannon et at., Cold Spring Harbor Symp. Quant. Biol. 51, 785 (1986); P. Charmley, P. Concannon, R. A. Gatti, Tissue Antigens 35, 157 (1990); P Charmley, K. Wang, L. Hood, D. Nickerson. J. Exp. Med 177, 135 (1993); S W. Funkhouser, P. Concannon, P. Charmley, D. L. Vredevoe, L. Hood, Arthritis Hheum. 35, 466 (1992). the number of sequence variations obtained from our analysis of overlapping cosmids is too small to draw generalizations about the frequency of coding versus noncoding polymorphisms in the germline sequence.
52. E Seboun, M. A. Robinson, T. J. Kindt, S. I. Hauser, J. Exp. Med. 170, 1263 (1989).
53. P. L. Deininger and M. A. Batzer, Evol. Biol. 27, 157 (1993), A. F. A. Smit and A. D. Riggs, Nucleic Acids Res. 23, 98 (1995)
54. P. L. Deininger and M. A. Batzer, Evol. Biol. 27, 157 (1993), A. F. A. Smit and A. D. Riggs, Nucleic Acids Res. 23, 98 (1995)
55. A. F. A. Smit, G Toth, A. D. Riggs, J. Jurka, J. Mol. Biol. 246, 401 (1995).
56. A F A. Smit, Nucleic Acids Res. 21, 1863 (1993).
57. D. A. Wilkinson, D. L Mager, J. A. C. Leong, in The Retroviridae, J. A. Levy, Ed. (Plenum, New York, 1994) vol. 3, pp. 465-535
58. A. F. A. Smit and A. D. Riggs, Proc Natl. Acad. Sci. U.S A. 93, 1443 (1996).
59. G. P. Holmquist, Am. J. Hum. Genet. 51, 17 (1992).
60. A. Smit, personal communication.
61. P Concannon, Manual of Clinical Immunology (American Society for Microbiology, Washington, DC, 1992), pp. 885-889.
62. P Charmley, P. Concannon, L. Hood, L. Rowen, Genomics 29, 760 (1995).
63. S. F. Altschul, W. Gish, W. Miller, E. W. Myers, D. J Lipman, J. Mol. Biol. 215, 403 (1990).
64. L. Rowen et al., in preparation.
65. We thank A Smit for extensive analysis of genomewide interspersed repeats in this sequence; P. Green for cross_match, a sequence comparison program; X. Huang for his multiple sequence alignment program (MAP); D. Gordon and T. Smith for computer scripts; K Cattell for the MpSRCH analysis, Applied Biosystems and Masspar for allowing us to use early test software; technicians at the California Institute of Technology and the University of Washington for performing the DNA sequencing; P. Charmley for helpful discussion; and M. E. Aheam for technical assistance. B.F.K. thanks Canadian Genome Analysis and Technology and the Natural Sciences and Engineering Research Council of Canada for their support. Supported by grants from the Department of Energy and NIH.